Kawasaki disease following coronavirus disease 2019 with prolonged fecal viral shedding
Corresponding Author
Kazuhiro Uda
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Correspondence: Kazuhiro Uda, MD, Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan. Email: [email protected]
Search for more papers by this authorKeiko Okita
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorKeiko Soneda
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorKimihiro Taniguchi
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorYuho Horikoshi
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Western Pacific Regional Office, World Health Organization, Kuala Lumpur, Malaysia
Search for more papers by this authorCorresponding Author
Kazuhiro Uda
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Correspondence: Kazuhiro Uda, MD, Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, 2-8-29 Musashidai, Fuchu, Tokyo 183-8561, Japan. Email: [email protected]
Search for more papers by this authorKeiko Okita
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorKeiko Soneda
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorKimihiro Taniguchi
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Search for more papers by this authorYuho Horikoshi
Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Fuchu, Tokyo, Japan
Western Pacific Regional Office, World Health Organization, Kuala Lumpur, Malaysia
Search for more papers by this authorDisclosure
The authors declare no conflicts of interest.
Supporting Information
| Filename | Description |
|---|---|
| ped14452-sup-0001-TableS1.docxWord document, 23.2 KB | Table S1. Laboratory data at second admission. |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- 1Feldstein LR, Rose EB, Horwitz SM et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020; 383: 334–46.
- 2Belot A, Antona D, Renolleau S et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro. Surveill. 2020; 25: 2001010.
10.2807/1560-7917.ES.2020.25.22.2001010 Google Scholar
- 3 The Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19). https://emergency.cdc.gov/han/2020/han00432.asp. (Accessed on July 19, 2020).
- 4 Royal College of Paediatrics and Child Health. Guidance - Paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf. (Accessed on July 19, 2020).
- 5Nakamura Y, Yashiro M, Uehara R et al. Epidemiologic features of Kawasaki disease in Japan: Results of the 2007–2008 nationwide survey. J. Epidemiol. 2010; 20: 302–7.
- 6Kobayashi T, Saji T, Otani T et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): A randomised, open-label, blinded-endpoints trial. Lancet 2012; 379: 1613–20.
- 7 Tokyo Metropilitan Infectious Disease Surveillance Center. Infectious diseases weekly report. http://idsc.tokyo-eiken.go.jp/assets/weekly/2020/30.pdf. (Accessed on August 9, 2020).
Citing Literature
